[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:pulmonary-arterial-hypertension":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":266,"states":267},"Pulmonary Arterial Hypertension",42,35,[8,16,23,29,35,41,47,53,59,66,72,78,84,89,95,101,107,113,119,126,132,138,144,150,156,162,168,174,180,186,192,198,204,209,215,221,228,234,240,247,253,260],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06992440","Empagliflozin to Improve Right Ventricular Function in Pulmonary Arterial Hypertension",[12],"Phase 2","RECRUITING","2026-08-26T02:18:12.612955Z","2026-07-24T01:27:14.872566Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT07481981","A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)",[20],"Phase 3","2026-08-26T02:18:53.782384Z","2026-05-29T15:36:40.189236Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT07365332","An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)",[20],"2026-08-26T02:19:26.493949Z","2026-05-13T02:55:06.698773Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT07132788","Understanding the Effects of Pulmonary Arterial Hypertension on Lean Muscle Mass",[],"2026-08-26T02:15:44.309045Z","2026-05-13T02:55:06.657591Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":39,"content_modified":40},"NCT01712620","Spironolactone for Pulmonary Arterial Hypertension",[12],"2026-08-26T02:15:03.757872Z","2026-05-05T02:43:29.702429Z",{"nct_id":42,"title":43,"phases":44,"status":13,"updated_at":45,"content_modified":46},"NCT07218029","A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)",[20],"2026-08-26T02:16:17.877565Z","2026-05-05T02:43:29.692365Z",{"nct_id":48,"title":49,"phases":50,"status":13,"updated_at":51,"content_modified":52},"NCT06941441","PAH Exercise Study",[20],"2026-08-26T02:19:19.975067Z","2026-05-05T02:43:29.050131Z",{"nct_id":54,"title":55,"phases":56,"status":13,"updated_at":57,"content_modified":58},"NCT07318597","Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)",[12],"2026-08-26T02:17:20.511551Z","2026-05-05T02:43:28.869051Z",{"nct_id":60,"title":61,"phases":62,"status":13,"updated_at":64,"content_modified":65},"NCT06649110","A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)",[63],"Phase 1\u002FPhase 2","2026-08-26T02:16:31.714843Z","2026-05-05T02:43:28.218883Z",{"nct_id":67,"title":68,"phases":69,"status":13,"updated_at":70,"content_modified":71},"NCT07073820","A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489",[12],"2026-08-03T03:36:30.249914Z","2026-05-05T02:43:28.206198Z",{"nct_id":73,"title":74,"phases":75,"status":13,"updated_at":21,"content_modified":77},"NCT06872112","A Study Evaluating the Safety and Tolerability of Artesunate in Patients With Pulmonary Arterial Hypertension",[76],"Phase 1","2026-05-05T02:43:27.675626Z",{"nct_id":79,"title":80,"phases":81,"status":13,"updated_at":82,"content_modified":83},"NCT06053580","Repurposing Valsartan May Protect Against Pulmonary Hypertension",[12],"2026-08-26T02:17:14.343713Z","2026-05-05T02:43:27.608272Z",{"nct_id":85,"title":86,"phases":87,"status":13,"updated_at":33,"content_modified":88},"NCT05587712","Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)",[12],"2026-05-05T02:43:27.516673Z",{"nct_id":90,"title":91,"phases":92,"status":13,"updated_at":93,"content_modified":94},"NCT06549452","Mobile Health Intervention to Improve Exercise in Pediatric PH",[],"2026-08-26T02:18:21.216897Z","2026-05-05T02:35:31.914292Z",{"nct_id":96,"title":97,"phases":98,"status":13,"updated_at":99,"content_modified":100},"NCT04062565","Trial to Evaluate Parenteral Treprostinil and Riociguat on Right Ventriculo-vascular Coupling and Morphology in Those With Advanced PAH",[20],"2026-08-26T02:17:54.420226Z","2026-05-05T02:35:31.745783Z",{"nct_id":102,"title":103,"phases":104,"status":13,"updated_at":105,"content_modified":106},"NCT05464095","The MObile Health InterVEntion in Pulmonary Arterial Hypertension (MOVE PAH) Study",[],"2026-08-26T02:19:16.454910Z","2026-04-29T02:57:57.159440Z",{"nct_id":108,"title":109,"phases":110,"status":13,"updated_at":111,"content_modified":112},"NCT07175038","A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)",[12],"2026-08-26T02:15:21.365312Z","2026-05-05T02:43:27.062073Z",{"nct_id":114,"title":115,"phases":116,"status":13,"updated_at":117,"content_modified":118},"NCT04555161","Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System",[],"2026-08-26T02:15:25.633039Z","2026-05-05T02:43:27.624232Z",{"nct_id":120,"title":121,"phases":122,"status":13,"updated_at":124,"content_modified":125},"NCT05452889","PET Image in PAH Patients",[123],"Early Phase 1","2026-08-26T02:15:30.699880Z","2026-05-05T02:43:28.879432Z",{"nct_id":127,"title":128,"phases":129,"status":13,"updated_at":130,"content_modified":131},"NCT06351345","129 Xenon Imaging in Patients Treated With Sotatercept",[12],"2026-08-26T02:19:10.436356Z","2026-05-05T02:43:28.401841Z",{"nct_id":133,"title":134,"phases":135,"status":13,"updated_at":136,"content_modified":137},"NCT06104228","129 Xenon MRI as a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension (PAH)",[12],"2026-08-26T02:17:01.714035Z","2026-05-05T02:43:27.672925Z",{"nct_id":139,"title":140,"phases":141,"status":13,"updated_at":142,"content_modified":143},"NCT04991454","Xenon MRI Pulm Hypertension",[12],"2026-08-26T02:17:34.833510Z","2026-05-05T02:43:28.851383Z",{"nct_id":145,"title":146,"phases":147,"status":13,"updated_at":148,"content_modified":149},"NCT04778046","Pulmonary Hypertension SOLAR",[12],"2026-08-26T02:17:49.709549Z","2026-05-05T02:43:26.974534Z",{"nct_id":151,"title":152,"phases":153,"status":13,"updated_at":154,"content_modified":155},"NCT07613099","Evaluation of Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74 PET\u002FCT Imaging)",[20],"2026-08-26T02:18:00.873391Z","2026-05-29T15:36:40.234557Z",{"nct_id":157,"title":158,"phases":159,"status":13,"updated_at":160,"content_modified":161},"NCT06274801","Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)",[20],"2026-08-26T02:19:22.562392Z","2026-07-30T01:46:14.437792Z",{"nct_id":163,"title":164,"phases":165,"status":13,"updated_at":166,"content_modified":167},"NCT01730092","Natural History Study of Biomarkers in Pulmonary Arterial Hypertension",[],"2026-08-26T02:18:08.005333Z","2026-07-05T05:32:16.770974Z",{"nct_id":169,"title":170,"phases":171,"status":13,"updated_at":172,"content_modified":173},"NCT05584722","Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible Individuals",[],"2026-08-26T02:15:24.145250Z","2026-05-13T02:55:06.363492Z",{"nct_id":175,"title":176,"phases":177,"status":13,"updated_at":178,"content_modified":179},"NCT02249923","Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry",[],"2026-08-26T02:18:41.390601Z","2026-05-13T02:55:06.091254Z",{"nct_id":181,"title":182,"phases":183,"status":13,"updated_at":184,"content_modified":185},"NCT04071327","Pulmonary Hypertension Association Registry",[],"2026-08-26T02:16:46.951087Z","2026-05-13T02:55:06.183346Z",{"nct_id":187,"title":188,"phases":189,"status":13,"updated_at":190,"content_modified":191},"NCT07217522","Rutgers University Study of the Genetics of Pulmonary Hypertension",[],"2026-08-26T02:15:40.343619Z","2026-05-13T02:55:06.674691Z",{"nct_id":193,"title":194,"phases":195,"status":13,"updated_at":196,"content_modified":197},"NCT04808596","Pulmonary Hypertension Biorepository and Registry",[],"2026-08-26T02:16:15.345907Z","2026-05-13T02:55:06.270820Z",{"nct_id":199,"title":200,"phases":201,"status":13,"updated_at":202,"content_modified":203},"NCT04278404","Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)",[],"2026-08-26T02:19:13.549512Z","2026-05-13T02:55:06.246558Z",{"nct_id":205,"title":206,"phases":207,"status":13,"updated_at":154,"content_modified":208},"NCT01884051","Hormonal, Metabolic, and Signaling Interactions in PAH",[],"2026-05-13T02:55:06.080964Z",{"nct_id":210,"title":211,"phases":212,"status":13,"updated_at":213,"content_modified":214},"NCT06481852","A Placebo-controlled, Randomized Clinical Trial to Assess the Safety, Feasibility, and Pharmacokinetics of Microbiota Transplant Therapy With Antibiotic Preconditioning and Fiber Supplementation in Patients With Pulmonary Arterial Hypertension",[76],"2026-08-26T02:16:47.762107Z","2026-04-29T02:57:57.107598Z",{"nct_id":216,"title":217,"phases":218,"status":13,"updated_at":219,"content_modified":220},"NCT02966665",": Vascular Function in Health and Disease",[76],"2026-08-26T02:16:21.385056Z","2026-05-05T02:43:28.301631Z",{"nct_id":222,"title":223,"phases":224,"status":225,"updated_at":226,"content_modified":227},"NCT07601295","Tiprelestat Versus Placebo When Added to Standard of Care for the Treatment of Pulmonary Arterial Hypertension (PAH)",[12],"NOT_YET_RECRUITING","2026-08-26T02:18:32.765187Z","2026-05-29T15:36:40.220514Z",{"nct_id":229,"title":230,"phases":231,"status":225,"updated_at":232,"content_modified":233},"NCT06802380","Neuromodulation in Patients With Pulmonary Arterial Hypertension",[63],"2026-08-26T02:17:19.710918Z","2026-05-05T02:43:29.224247Z",{"nct_id":235,"title":236,"phases":237,"status":225,"updated_at":238,"content_modified":239},"NCT07487441","Reverse Remodeling of the Pulmonary Vasculature: a Longitudinal, Investigational Study of the Effects of Sotatercept.",[],"2026-08-26T02:15:52.238965Z","2026-05-13T02:55:06.708875Z",{"nct_id":241,"title":242,"phases":243,"status":244,"updated_at":245,"content_modified":246},"NCT03683186","A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension",[20],"ENROLLING_BY_INVITATION","2026-08-26T02:18:24.494016Z","2026-06-16T05:54:07.969216Z",{"nct_id":248,"title":249,"phases":250,"status":244,"updated_at":251,"content_modified":252},"NCT04930289","Global Utilization And Registry Database for Improved preservAtion of doNor LUNGs",[],"2026-08-26T02:16:44.178623Z","2026-07-05T18:42:10.714896Z",{"nct_id":254,"title":255,"phases":256,"status":257,"updated_at":258,"content_modified":259},"NCT06477640","Home Rehabilitation Improves Cardiac Effort in Pulmonary Arterial Hypertension",[],"ACTIVE_NOT_RECRUITING","2026-08-03T01:59:18.089574Z","2026-05-05T02:43:27.799150Z",{"nct_id":261,"title":262,"phases":263,"status":257,"updated_at":264,"content_modified":265},"NCT03838445","Reducing Right Ventricular Failure in Pulmonary Arterial Hypertension (RELIEVE-PAH)",[],"2026-08-03T03:18:43.458685Z","2026-05-05T02:43:27.422346Z",[],[268,272,276,280,284,287,291,294,297,300,303,307,310,314,317,320,324,327,330,333,337,340,343,347],{"state":269,"count":270,"slug":271},"California",16,"california",{"state":273,"count":274,"slug":275},"Pennsylvania",13,"pennsylvania",{"state":277,"count":278,"slug":279},"North Carolina",12,"north-carolina",{"state":281,"count":282,"slug":283},"Colorado",11,"colorado",{"state":285,"count":282,"slug":286},"Tennessee","tennessee",{"state":288,"count":289,"slug":290},"Arizona",10,"arizona",{"state":292,"count":289,"slug":293},"Maryland","maryland",{"state":295,"count":289,"slug":296},"Massachusetts","massachusetts",{"state":298,"count":289,"slug":299},"Ohio","ohio",{"state":301,"count":289,"slug":302},"Texas","texas",{"state":304,"count":305,"slug":306},"Florida",9,"florida",{"state":308,"count":305,"slug":309},"New York","new-york",{"state":311,"count":312,"slug":313},"Kansas",7,"kansas",{"state":315,"count":312,"slug":316},"Kentucky","kentucky",{"state":318,"count":312,"slug":319},"Washington","washington",{"state":321,"count":322,"slug":323},"Oregon",6,"oregon",{"state":325,"count":322,"slug":326},"Rhode Island","rhode-island",{"state":328,"count":322,"slug":329},"South Carolina","south-carolina",{"state":331,"count":322,"slug":332},"Wisconsin","wisconsin",{"state":334,"count":335,"slug":336},"Minnesota",5,"minnesota",{"state":338,"count":335,"slug":339},"Utah","utah",{"state":341,"count":335,"slug":342},"Virginia","virginia",{"state":344,"count":345,"slug":346},"Georgia",4,"georgia",{"state":348,"count":345,"slug":349},"Indiana","indiana"]